Mount Sinai Psychiatry Residents Win Multiple National Awards
Psychiatry residents at the Icahn School of Medicine at Mount Sinai have been awarded several prestigious national prizes and fellowships this year in recognition of their exceptional patient care, outstanding leadership, and remarkable research prowess. Jessica...
APA 2019: Ketamine and Deep Brain Stimulation
On May 19, James Murrough, MD, PhD, director of Mount Sinai's Depression and Anxiety Center for Discovery and Treatment, and Martijn Figee, MD, director of Mount Sinai’s Interventional Psychiatry Program, chaired a session on next-generation solutions for treatment...
APA 2019: Child Separation and the Impact on Mental Health and Resilience
At the American Psychiatric Association’s 2019 Annual Meeting in San Francisco on May 21, Rachel Yehuda, PhD, director of Mount Sinai’s Traumatic Stress Studies Program, and Adriana Feder, MD, director of Mount Sinai’s Trauma and Resilience Program, chaired a session...
APA 2019: Innovation Lab Grand Prize Winners
On Monday, May 20, a group from the Icahn School of Medicine at Mount Sinai won the $10,000 grand prize at the Psychiatry Innovation Lab at the American Psychiatric Association’s (APA) 2019 Annual Meeting in San Francisco. The APA’s annual “Shark Tank style”...
Hot on the Trail: Schizophrenia
On April 23, Dolores Malaspina, MD, MS, MSPH, published results of a study on marriage duration and how it affects schizophrenia risk in offspring. She found that if a specific man and a woman had a shorter duration of sexual contact before conception, their child...
30 Years on the Forefront of Trauma Research
Dr. Yehuda in Burlington, Vermont, where she was giving a talk about molecular markers of suicide risk in returning veterans. In January, Rachel Yehuda, MS, PhD, was in Israel learning how to use MDMA-assisted psychotherapy to treat PTSD. MDMA, sometimes known as...